Jim Mazzola | Senior Vice President, Communication and Investor Relations |
Athena Countouriotis | President and Chief Executive Officer |
Yi Larson | Executive Vice President and Chief Financial Officer |
Michael Schmidt | Guggenheim Securities |
Paul Choi | Goldman Sachs |
Andrew Berens | SVB Leerink |
Arlinda Lee | Canaccord Genuity |
Yanan Zhu | Wells Fargo Securities LLC |
Good afternoon, ladies and gentlemen, and welcome to the Turning Point Therapeutics' Third Quarter 2019 Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host, Mr.